Evrysdi Side Effects
Generic name: risdiplam
Medically reviewed by Drugs.com. Last updated on Oct 23, 2024.
Note: This document provides detailed information about Evrysdi Side Effects associated with risdiplam. Some dosage forms listed on this page may not apply specifically to the brand name Evrysdi.
Applies to risdiplam: oral powder for solution.
Serious side effects of Evrysdi
Along with its needed effects, risdiplam (the active ingredient contained in Evrysdi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking risdiplam:
More common side effects
Less common side effects
- bladder pain
- bloody or cloudy urine
- difficult, burning, or painful urination
- frequent urge to urinate
- lower back or side pain
Other side effects of Evrysdi
Some side effects of risdiplam may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- canker sores
- constipation
- diarrhea
- skin rash
- sores, ulcers, or white spots on the lips or tongue or inside the mouth
- vomiting
Less common side effects
- difficulty in moving
- joint pain
- muscle pain or stiffness
For healthcare professionals
Applies to risdiplam: oral powder for reconstitution, oral tablet.
General adverse events
The most frequently reported side effects included fever, diarrhea, headache, and rash. Additionally, among patients with infantile-onset spinal muscular atrophy, upper respiratory tract infection, lower respiratory tract infection, constipation, vomiting, and cough were reported.[Ref]
Dermatologic
- Very common (10% or more): Rash (up to 17%)
- Common (1% to 10%): Eczema
- Postmarketing reports: Cutaneous vasculitis
Rash included dermatitis, rash, erythema, maculo-papular rash, erythematous rash, popular rash, allergic dermatitis, acneiform dermatitis, and folliculitis.
Cutaneous vasculitis was identified during post-marketing experience.
Endocrine
- Common (1% to 10%): Cryptorchism
Gastrointestinal
- Very common (10% or more): Constipation (up to 25%), diarrhea (up to 17%), vomiting (up to 17%)
- Common (1% to 10%): Mouth and aphthous ulcers, gastroesophageal reflux disease, gastroenteritis, nausea, upper abdominal pain
Genitourinary
- Common (1% to 10%): Urinary tract infection
Urinary tract infection included urinary tract infection and cystitis.
Musculoskeletal
- Common (1% to 10%): Arthralgia, joint dislocation
Nervous system
- Very common (10% or more): Headache (20%)
Other
- Very common (10% or more): Pyrexia (up to 54%), teething (up to 13%)
- Common (1% to 10%): Ear infection
Pyrexia included fever and hyperpyrexia.
Respiratory
- Very common (10% or more): Upper respiratory tract infection (up to 82%), pneumonia (up to 40%), cough (12.9%), bronchitis (up to 11%)
- Common (1% to 10%): Respiratory failure, respiratory distress, acute respiratory failure, atelectasis
- Frequency not reported: Lower respiratory tract infection
Upper respiratory tract infections included nasopharyngitis, respiratory tract infection, rhinitis, influenza, pharyngitis, viral respiratory tract infection, upper respiratory tract infection (bacterial and viral), and COVID-19.
Lower respiratory tract infection included pneumonia and bronchitis.
References
1. (2020) "Product Information. Evrysdi (risdiplam)." Genentech
2. (2024) "Product Information. Evrysdi (risdiplam)." Genentech
3. (2023) "Product Information. Evrysdi (risdiplam)." Roche Products Pty Ltd
4. (2023) "Product Information. Evrysdi (risdiplam)." Roche Products Ltd
Frequently asked questions
- Evrysdi vs Spinraza: How do they compare?
- How does Evrysdi work for SMA?
- How effective is Evrysdi?
- Does Evrysdi cure spinal muscular atrophy (SMA)?
- How is Evrysdi administered?
More about Evrysdi (risdiplam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Evrysdi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.